GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:GXI - DE000A0LD6E6 - Common Stock
26.9 EUR
-0.74 (-2.68%)
Overall GXI gets a fundamental rating of 3 out of 10. We evaluated GXI against 21 industry peers in the Life Sciences Tools & Services industry. GXI may be in some trouble as it scores bad on both profitability and health. GXI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year GXI was profitable.
In the past year GXI had a positive cash flow from operations.
Each year in the past 5 years GXI has been profitable.
In the past 5 years GXI always reported a positive cash flow from operatings.
1.2 Ratios
GXI's Return On Assets of 0.50% is on the low side compared to the rest of the industry. GXI is outperformed by 80.95% of its industry peers.
Looking at the Return On Equity, with a value of 1.67%, GXI is doing worse than 76.19% of the companies in the same industry.
With a Return On Invested Capital value of 2.79%, GXI is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for GXI is below the industry average of 9.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROIC | 2.79% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
Looking at the Profit Margin, with a value of 1.04%, GXI is doing worse than 80.95% of the companies in the same industry.
In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
With a Operating Margin value of 5.99%, GXI is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
GXI's Operating Margin has improved in the last couple of years.
GXI has a worse Gross Margin (26.89%) than 76.19% of its industry peers.
In the last couple of years the Gross Margin of GXI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
GXI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GXI has about the same amount of shares outstanding.
Compared to 5 years ago, GXI has more shares outstanding
GXI has a worse debt/assets ratio than last year.
2.2 Solvency
GXI has an Altman-Z score of 0.96. This is a bad value and indicates that GXI is not financially healthy and even has some risk of bankruptcy.
GXI's Altman-Z score of 0.96 is on the low side compared to the rest of the industry. GXI is outperformed by 80.95% of its industry peers.
GXI has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of GXI (1.22) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.96 |
ROIC/WACC0.33
WACC8.39%
2.3 Liquidity
GXI has a Current Ratio of 0.98. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of GXI (0.98) is worse than 76.19% of its industry peers.
A Quick Ratio of 0.52 indicates that GXI may have some problems paying its short term obligations.
With a Quick ratio value of 0.52, GXI is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 |
3. Growth
3.1 Past
The earnings per share for GXI have decreased strongly by -19.08% in the last year.
GXI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.23% yearly.
Looking at the last year, GXI shows a quite strong growth in Revenue. The Revenue has grown by 11.83% in the last year.
The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
3.2 Future
The Earnings Per Share is expected to grow by 6.02% on average over the next years.
Based on estimates for the next years, GXI will show a small growth in Revenue. The Revenue will grow by 7.40% on average per year.
EPS Next Y-33.84%
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
EPS Next 5Y6.02%
Revenue Next Year13.08%
Revenue Next 2Y8.77%
Revenue Next 3Y7.87%
Revenue Next 5Y7.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 7.29, which indicates a rather cheap valuation of GXI.
Compared to the rest of the industry, the Price/Earnings ratio of GXI indicates a rather cheap valuation: GXI is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.59. GXI is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 8.00 indicates a reasonable valuation of GXI.
GXI's Price/Forward Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.03, GXI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.29 | ||
| Fwd PE | 8 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GXI is valued cheaply inside the industry as 95.24% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.46 |
4.3 Compensation for Growth
GXI's earnings are expected to decrease with -4.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
5. Dividend
5.1 Amount
GXI has a yearly dividend return of 0.15%, which is pretty low.
In the last 3 months the price of GXI has falen by -22.39%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
GXI's Dividend Yield is slightly below the industry average, which is at 0.54.
Compared to an average S&P500 Dividend Yield of 1.88, GXI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.15% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
GXI pays out 10.12% of its income as dividend. This is a sustainable payout ratio.
GXI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP10.12%
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
FRA:GXI (12/23/2025, 7:00:00 PM)
26.9
-0.74 (-2.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.82%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap929.13M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts65.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.15% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-3.39%
PT rev (3m)-41.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.91%
EPS NY rev (1m)-1.1%
EPS NY rev (3m)-19.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.83%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-4.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.29 | ||
| Fwd PE | 8 | ||
| P/S | 0.41 | ||
| P/FCF | N/A | ||
| P/OCF | 3.66 | ||
| P/B | 0.66 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.46 |
EPS(TTM)3.69
EY13.72%
EPS(NY)3.36
Fwd EY12.49%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY27.3%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROCE | 3.76% | ||
| ROIC | 2.79% | ||
| ROICexc | 2.93% | ||
| ROICexgc | 5.89% | ||
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.4 | ||
| Cap/Depr | 134.54% | ||
| Cap/Sales | 15.12% | ||
| Interest Coverage | 1.65 | ||
| Cash Conversion | 65.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 0.96 |
F-Score4
WACC8.39%
ROIC/WACC0.33
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-33.84%
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
EPS Next 5Y6.02%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year13.08%
Revenue Next 2Y8.77%
Revenue Next 3Y7.87%
Revenue Next 5Y7.4%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year91.04%
EBIT Next 3Y32.46%
EBIT Next 5Y21.19%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%
GERRESHEIMER AG / GXI.DE FAQ
What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.
What is the valuation status of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.
How profitable is GERRESHEIMER AG (GXI.DE) stock?
GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.
How financially healthy is GERRESHEIMER AG?
The financial health rating of GERRESHEIMER AG (GXI.DE) is 0 / 10.
What is the expected EPS growth for GERRESHEIMER AG (GXI.DE) stock?
The Earnings per Share (EPS) of GERRESHEIMER AG (GXI.DE) is expected to decline by -33.84% in the next year.